NanoVibronix

Elmsford, United States Founded: 2003 • Age: 23 yrs
Provider of ultrasound therapy devices for multiple health purposes
Request Access

About NanoVibronix

NanoVibronix is a company based in Elmsford (United States) founded in 2003.. NanoVibronix has raised $10.89 million across 18 funding rounds. The company has 31 employees as of December 31, 2024. NanoVibronix offers products and services including PainShield and UroShield. NanoVibronix operates in a competitive market with competitors including Camstent, BioDerm, ProvenMed, Aurie and FLUME, among others.

  • Headquarter Elmsford, United States
  • Employees 31 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Nanovibronix, Inc.
Operational Areas
Healthcare → Health Technology & Digital Health
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $2.56 M
    12.05
    as on Dec 31, 2024
  • Net Profit
    $-3.71 M
    0.16
    as on Dec 31, 2024
  • EBITDA
    $-3.58 M
    -4.25
    as on Dec 31, 2024
  • Total Equity Funding
    $10.89 M (USD)

    in 18 rounds

  • Latest Funding Round
    $50 M (USD), Post-IPO

    Jul 18, 2025

  • Investors
  • Employee Count
    31

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of NanoVibronix

NanoVibronix is a publicly listed company on the NASDAQ with ticker symbol NAOV in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: NAOV . Sector: Health technology · USA

Products & Services of NanoVibronix

NanoVibronix offers a comprehensive portfolio of products and services, including PainShield and UroShield. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Wearable ultrasound for treating chronic pain and soft tissue damage.

Ultrasound device to reduce bacterial colonization and urinary infections.

People of NanoVibronix
Headcount 1-10
Employee Profiles 5
Board Members and Advisors 6
Employee Profiles
People
Lindsey Harrison
Vice President of Sales
People
Steve Brown
Chief Financial Officer
People
Efrat Varsano
QA/RA Manager

Unlock access to complete

Board Members and Advisors
people
Thomas R. Mika
Director

Unlock access to complete

Funding Insights of NanoVibronix

NanoVibronix has successfully raised a total of $10.89M across 18 strategic funding rounds. The most recent funding activity was a Post-IPO round of $50 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 18
  • Last Round Post-IPO — $50.0M
  • First Round

    (04 Nov 2003)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2025 Amount Post-IPO - NanoVibronix Valuation

investors

Aug, 2023 Amount Post-IPO - NanoVibronix Valuation

investors

Jun, 2022 Amount Post-IPO - NanoVibronix Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by NanoVibronix

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - NanoVibronix

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Nanovibronix Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of NanoVibronix

NanoVibronix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Camstent, BioDerm, ProvenMed, Aurie and FLUME, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Polymer coating for medical devices
domain founded_year HQ Location
Hydrocolloid products are developed for urinary management and skin protection.
domain founded_year HQ Location
Devices for urinary incontinence treatment are provided by ProvenMed.
domain founded_year HQ Location
Automated reusable self-catheter systems are developed for urinary retention patients.
domain founded_year HQ Location
Developer of a catheter for the treatment of urinary incontinence
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Nanovibronix

Frequently Asked Questions about NanoVibronix

When was NanoVibronix founded?

NanoVibronix was founded in 2003.

Where is NanoVibronix located?

NanoVibronix is headquartered in Elmsford, United States. It is registered at Elmsford, New York, United States.

Who is the current CEO of NanoVibronix?

Harold Jacob is the current CEO of NanoVibronix.

Is NanoVibronix a funded company?

NanoVibronix is a funded company, having raised a total of $10.89M across 18 funding rounds to date. The company's 1st funding round was a Post-IPO of $250K, raised on Nov 04, 2003.

How many employees does NanoVibronix have?

As of Dec 31, 2024, the latest employee count at NanoVibronix is 31.

What is the annual revenue of NanoVibronix?

Annual revenue of NanoVibronix is $2.56M as on Dec 31, 2024.

What does NanoVibronix do?

NanoVibronix was founded in 2003 and is headquartered in Elmsford, United States. Ultrasound therapy devices are developed using proprietary low-frequency, low-intensity acoustic wave technology. Disposable transducers are utilized to transmit waves that aid in pain elimination, musculoskeletal and vascular tissue regeneration, and biofilm reduction on urinary catheters to lower CAUTI risks. Operations focus on the medical device sector for various therapeutic applications.

Who are the top competitors of NanoVibronix?

NanoVibronix's top competitors include Camstent, BioDerm and Aurie.

What products or services does NanoVibronix offer?

NanoVibronix offers PainShield and UroShield.

Is NanoVibronix publicly traded?

Yes, NanoVibronix is publicly traded on NASDAQ under the ticker symbol NAOV.

What is NanoVibronix's ticker symbol?

The ticker symbol of NanoVibronix is NAOV on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available